New York-based MindMed has applied for a Nasdaq up-listing and is valued at $190 million.
New data reveal that taking psychedelics may impact users in a way similar to having a mystical or religious experience.
We sit down with Dr. Albert Garcia-Romeu of Johns Hopkins Center for Psychechedelic & Consciousness Research.
The John Hopkins Center for Psychedelic & Consciousness Research will create the largest registry on psilocybin use.
The Ann Arbor City Council voted this week to decriminalize psychedelic substances.